Inovio Pharmaceuticals, Inc.
(NASDAQ : INO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic Plc -2.28%89.840.6%$902.31m
ABTAbbott Laboratories -1.61%74.590.8%$887.44m
TMOThermo Fisher Scientific, Inc. -2.85%275.081.0%$886.57m
ISRGIntuitive Surgical, Inc. -2.21%490.412.4%$706.34m
DHRDanaher Corp. -0.23%138.340.7%$706.33m
BDXBecton, Dickinson & Co. -1.22%216.671.1%$647.07m
SYKStryker Corp. -2.66%158.991.3%$568.43m
BSXBoston Scientific Corp. -2.61%30.601.1%$492.72m
INOInovio Pharmaceuticals, Inc. 16.36%8.326.8%$491.36m
EWEdwards Lifesciences Corp. -0.44%198.571.2%$457.96m
DXCMDexCom, Inc. 5.10%262.968.2%$383.35m
BAXBaxter International, Inc. -0.51%79.761.8%$375.87m
ZBHZimmer Biomet Holdings, Inc. -5.81%94.991.7%$258.94m
ALGNAlign Technology, Inc. -7.62%177.046.4%$254.68m
IDXXIDEXX Laboratories, Inc. 0.60%231.753.8%$236.04m

Company Profile

Inovio Pharmaceuticals, Inc. is a late-stage biotechnology company. It engages in the discovery, development, and commercialization of DNA-based immunotherapies and vaccines. The firm's drug candidates include SynCon immunotherapies which helps break the immune system's tolerance of cancerous cells; and CELLECTRA delivery system which facilitates optimized cellular uptake of the SynCon immunotherapies. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.